BH3 Mimetics for the Treatment of B-Cell Malignancies—Insights and Lessons from the Clinic
The discovery of the link between defective apoptotic regulation and cancer cell survival engendered the idea of targeting aberrant components of the apoptotic machinery for cancer therapy. The intrinsic pathway of apoptosis is tightly controlled by interactions amongst members of three distinct sub...
Main Authors: | Victor S. Lin, Zhuo-Fan Xu, David C. S. Huang, Rachel Thijssen |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-11-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/11/3353 |
Similar Items
-
Restoring Apoptosis with BH3 Mimetics in Mature B-Cell Malignancies
by: Maxime Jullien, et al.
Published: (2020-03-01) -
BH3 Mimetics in Hematologic Malignancies
by: Pavel Klener, et al.
Published: (2021-09-01) -
Etude de la voie non-apoptotique induite par le récepteur CD95 : application dans les cancers du sein triple négatifs et développement thérapeutique
by: Fouqué, Amélie
Published: (2015) -
AT101 [(-)-Gossypol] Selectively Inhibits MCL1 and Sensitizes Carcinoma to BH3 Mimetics by Inducing and Stabilizing NOXA
by: David J. Mallick, et al.
Published: (2020-08-01) -
BCL-2 as therapeutic target for hematological malignancies
by: Guilherme Fleury Perini, et al.
Published: (2018-05-01)